Brian H. LaFranchi

ORCID: 0009-0007-2019-3494
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Long-Term Effects of COVID-19
  • Intensive Care Unit Cognitive Disorders
  • COVID-19 Clinical Research Studies
  • Immune cells in cancer
  • Innovation and Socioeconomic Development
  • HIV Research and Treatment
  • Immune Cell Function and Interaction
  • CRISPR and Genetic Engineering

University of California, San Francisco
2023-2024

The mechanisms of postacute medical conditions and unexplained symptoms after SARS-CoV-2 infection [Long Covid (LC)] are incompletely understood. There is growing evidence that viral persistence, immune dysregulation, T cell dysfunction may play major roles. We performed whole-body positron emission tomography imaging in a well-characterized cohort 24 participants at time points ranging from 27 to 910 days acute using the radiopharmaceutical agent [

10.1126/scitranslmed.adk3295 article EN Science Translational Medicine 2024-07-03

ABSTRACT The etiologic mechanisms of post-acute medical morbidities and unexplained symptoms (Long COVID) following SARS-CoV-2 infection are incompletely understood. There is growing evidence that viral persistence immune dysregulation may play a major role. We performed whole-body positron emission tomography (PET) imaging in cohort 24 participants at time points ranging from 27 to 910 days acute using novel radiopharmaceutical agent, [ 18 F]F-AraG, highly selective tracer allows for...

10.1101/2023.07.27.23293177 preprint EN cc-by medRxiv (Cold Spring Harbor Laboratory) 2023-07-31

Purpose of review Durable HIV-1 remission has been reported in a person who received allogeneic stem cell transplants (SCTs) involving CCR5 Δ32/Δ32 donor cells. Much the reduction burden following SCT with or without cells inherently resistant to infection is likely due cytotoxic graft-versus-host effects on residual recipient immune Nonetheless, there growing momentum develop and implement therapies that lead durable long-term antiretroviral therapy (ART)-free need for SCT. Recent findings...

10.1097/coh.0000000000000859 article EN Current Opinion in HIV and AIDS 2024-04-26
Coming Soon ...